{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T12:45:14Z","timestamp":1780836314191,"version":"3.54.1"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.3201\/eid3202.251111","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:44:53Z","timestamp":1770687893000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment"],"prefix":"10.3201","volume":"32","author":[{"given":"Lukasz","family":"Rojek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wnuk-Lipinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Adrych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3202.251111-202602091523-R1","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection.","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"key-10.3201\/eid3202.251111-202602091523-R2","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection [cited 2025 Dec 6]. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/34470cc8-af90-4d7b-a949-ef27e5d0726f\/content"},{"key":"key-10.3201\/eid3202.251111-202602091523-R3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis.","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"key-10.3201\/eid3202.251111-202602091523-R4","doi-asserted-by":"publisher","first-page":"2473222","DOI":"10.1080\/21645515.2025.2473222","article-title":"Mission 2030: Toward universal hepatitis B immunization.","volume":"21","author":"Broeckhoven","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid3202.251111-202602091523-R5","first-page":"1","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid3202.251111-202602091523-R6","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/v14081780","article-title":"Hepatitis B surface antibody (anti-HBs) kinetics during rituximab chemotherapy and performance of hepatitis B vaccine before immunosuppression: two prospective studies.","volume":"14","author":"Araujo-Neto","year":"2022","journal-title":"Viruses"},{"key":"key-10.3201\/eid3202.251111-202602091523-R7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"key-10.3201\/eid3202.251111-202602091523-R8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/10781552241232331","article-title":"Evaluation of second-generation Bruton\u2019s tyrosine kinase inhibitors for the treatment of mantle cell lymphoma.","volume":"31","author":"Lu","year":"2025","journal-title":"J Oncol Pharm Pract"},{"key":"key-10.3201\/eid3202.251111-202602091523-R9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.clml.2023.04.006","article-title":"Hepatitis B virus reactivation in patients receiving Bruton tyrosine kinase inhibitors.","volume":"23","author":"Chiu","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key-10.3201\/eid3202.251111-202602091523-R10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2024.11.008","article-title":"AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals.","volume":"168","author":"Ali","year":"2025","journal-title":"Gastroenterology"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:44:54Z","timestamp":1770687894000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/2\/25-1111_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3202.251111","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}